FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to psychiatry, and can be used for diagnosing asthenic syndrome in schizophrenic patients. That is ensured by measuring the enzymatic activity of leukocyte elastase and the functional activity of the alpha-1 proteinase inhibitor in the patient's blood serum of schizophrenia. If the ratio of the enzymatic activity of leukocyte elastase to the value of the functional activity of the alpha-1 proteinase inhibitor (leukocyte-inhibitor index) is within range of 3.10–4.34, the asthenia is diagnosed in the patient, and if this ratio is in range 4.85–6.31 – absence of asthenia.
EFFECT: invention provides objective diagnostics of schizoasthenia on the basis of proteolytic-inhibitor system of blood serum.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATION OF PATIENT'S MENTAL CONDITION WITH ENDOGENIC MENTAL DISORDERS AT THEIR CLINICAL EXAMINATION AND METHOD OF COMPLEX EVALUATION OF THE STATE OF THE IMMUNE SYSTEM OF SUCH PATIENTS | 2016 |
|
RU2648745C1 |
| METHOD FOR PREDICTING THE LIKELIHOOD OF DEVELOPING ALZHEIMER'S DISEASE (AD) | 2017 |
|
RU2663451C1 |
| METHOD OF DETERMINING THE NECESSITY OF USING PSYCHO PHARMACOTHERAPY AMONG THE PATIENTS WITH DISORDERS OF AUTIST SPECTRUM AT THE MOMENT OF THEIR EXAMINATION | 2017 |
|
RU2643760C1 |
| METHOD FOR PREDICTION OF FUNCTIONAL RECOVERY OF PATIENTS WITH ISCHEMIC STROKE | 2018 |
|
RU2694541C1 |
| METHOD OF PREDICTING PSYCHOMOTOR DEVELOPMENT OF CHILDREN WITH PERINATAL AFFECTION OF CENTRAL NERVOUS SYSTEM | 2011 |
|
RU2475747C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD OF LABORATORY DETECTION OF CONSEQUENCES OF PERINATAL CENTRAL NERVOUS SYSTEM AFFECTIONS AND SEVERITY DETERMINATION IN CHILDREN | 2010 |
|
RU2425371C1 |
| METHOD FOR PREDICTING THE FLOW OF SENSONEURAL IMPAIRED HEARING | 2005 |
|
RU2281509C1 |
| METHOD FOR DETECTING THE CHARACTER OF PATHOPHYSIOLOGICAL LESIONS IN PSYCHOMOTOR DEVELOPMENT IN CHILDREN OF FIRST YEAR OF LIFE | 2003 |
|
RU2231074C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
